Showing results (241-250 of 309) with videos related to
Sort By:
Pageof 31
BMC Hematology|July 7, 2018
Adapting medical guidelines to be patient-centered using a patient-driven process for individuals with sickle cell disease and their caregiversRobert Michael Cronin, Tilicia L Mayo-Gamble, Sarah-Jo Stimpson, et al.BMJ Open|November 18, 2021
Identifying barriers to evidence-based care for sickle cell disease: results from the Sickle Cell Disease Implementation Consortium cross-sectional survey of healthcare providers in the USAMatthew P Smeltzer, Kristen E Howell, Marsha Treadwell, et al.Journal of Sickle Cell Disease|June 17, 2025
Recommended measurement protocols for sickle cell disease in the PhenX toolkit: psychosocial factors and social determinants of healthLori E Crosby, Desireé N Williford, Allison A King, et al.Journal of Neurosurgical Anesthesiology|October 5, 2019
Ischemia-modified Albumin as a Biomarker for Prediction of Poor Outcome in Patients With Traumatic Brain Injury: An Observational Cohort StudyTarek A M Radwan, Rania S Fahmy, Mohamed F M El Emady, et al.International Journal of Biological Macromolecules|May 4, 2025
Sodium alginate-modified activated binder derived from TiO<sub>2</sub> nanoparticles and carbon-rich limestone: A new bio-based composite for methylene blue adsorptionBadria M Alshehri, Ahmed S Elshimy, Ahmed M Salah, et al.JMIR Research Protocols|May 14, 2021
Comparing the Effectiveness of Education Versus Digital Cognitive Behavioral Therapy for Adults With Sickle Cell Disease: Protocol for the Cognitive Behavioral Therapy and Real-time Pain Management Intervention for Sickle Cell via Mobile Applications (CaRISMA) StudySherif M Badawy, Kaleab Z Abebe, Charlotte A Reichman, et al.Pediatric Blood & Cancer|May 6, 2025
User Perceptions of a Multilevel mHealth Intervention to Boost Adherence to Hydroxyurea in Sickle Cell DiseaseChristina M Abrams, Natalia Davila, Sherif M Badawy, et al.Frontiers in Pharmacology|April 22, 2024
Chemotherapeutic potential of betanin/capecitabine combination targeting colon cancer: experimental and bioinformatic studies exploring NFκB and cyclin D1 interplayRehab Ahmed, Sawsan A Zaitone, Asmaa K K Abdelmaogood, et al.Pediatric Blood & Cancer|May 28, 2021
The ASH-ASPHO Choosing Wisely Campaign: 5 hematologic tests and treatments to questionSarah H O'Brien, Sherif M Badawy, Seth J Rotz, et al.Blood Advances|January 24, 2022
The ASH-ASPHO Choosing Wisely Campaign: 5 hematologic tests and treatments to questionSarah H O'Brien, Sherif M Badawy, Seth J Rotz, et al.Pageof 31